UPDATED Jul 04, 2022
Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2269WuXi Biologics (Cayman) | HK$77.55 | 1.2% | -43.8% | HK$327.2b | HK$107.74 | PE82.5x | E23.4% | n/a | ||
| 1177Sino Biopharmaceutical | HK$5.27 | 10.0% | -28.1% | HK$98.4b | HK$7.77 | PE5.8x | E-38.4% | 1.4% | ||
| 3692Hansoh Pharmaceutical Group | HK$16.36 | 3.0% | -50.3% | HK$96.9b | HK$22.97 | PE30.5x | E15.8% | 0.5% | ||
| 1093CSPC Pharmaceutical Group | HK$8.11 | 4.1% | -21.6% | HK$96.6b | HK$12.01 | PE14.9x | E9.5% | 2.1% | ||
| 1877Shanghai Junshi Biosciences | HK$43.45 | -3.2% | -29.5% | HK$71.7b | HK$61.35 | PS11.1x | E61.7% | n/a | ||
| 1548Genscript Biotech | HK$30.70 | 7.5% | -13.8% | HK$64.8b | HK$35.11 | PS16.2x | E54.5% | 0% | ||
| 874Guangzhou Baiyunshan Pharmaceutical Holdings | HK$23.10 | 0.4% | -2.3% | HK$57.2b | HK$23.32 | PE8.2x | E0.8% | 3.5% | ||
| 1801Innovent Biologics | HK$38.00 | 7.0% | -57.3% | HK$55.7b | HK$48.79 | PS11.1x | E58.8% | n/a | ||
| 6185CanSino Biologics | HK$81.75 | -7.1% | -78.4% | HK$37.4b | HK$181.63 | PE8.4x | E3.9% | 1.1% | ||
| 3320China Resources Pharmaceutical Group | HK$5.57 | 3.9% | 20.3% | HK$35.0b | HK$6.36 | PE9.3x | E1.9% | 2.7% | ||
| 9995RemeGen | HK$50.70 | 15.8% | -56.7% | HK$31.2b | HK$71.12 | PE134.2x | E80.5% | n/a | ||
| 867China Medical System Holdings | HK$12.50 | -0.5% | -37.4% | HK$30.7b | HK$16.89 | PE8.7x | E8.0% | 4.6% | ||
| 570China Traditional Chinese Medicine Holdings | HK$4.92 | 5.6% | -5.0% | HK$24.8b | HK$5.27 | PE10.9x | E13.6% | 2.8% | ||
| 9969InnoCare Pharma | HK$13.52 | -4.1% | -55.2% | HK$23.9b | HK$21.19 | PS19.5x | E46.6% | n/a | ||
| 2096Simcere Pharmaceutical Group | HK$8.78 | -8.4% | -33.4% | HK$23.2b | HK$13.26 | PE13.2x | E1.1% | 2.0% | ||
| 9926Akeso | HK$26.45 | 6.7% | -55.1% | HK$21.6b | HK$37.20 | PS81.8x | E55.3% | n/a | ||
| 6826Shanghai Haohai Biological Technology | HK$41.30 | 4.2% | -64.2% | HK$18.2b | HK$69.23 | PE19.5x | E20.6% | 2.0% | ||
| 512Grand Pharmaceutical Group | HK$4.74 | 4.2% | -32.1% | HK$16.7b | n/a | PE7x | S18.7% | 2.3% | ||
| 719Shandong Xinhua Pharmaceutical | HK$6.27 | 0.5% | 54.8% | HK$15.9b | n/a | PE10x | n/a | 2.8% | ||
| 15303SBio | HK$6.18 | -5.8% | -31.8% | HK$15.1b | HK$8.34 | PE7.8x | E6.9% | 3.2% | ||
| 2005SSY Group | HK$4.31 | 10.2% | -46.7% | HK$12.9b | HK$4.76 | PE16.4x | E27.4% | 3.2% | ||
| 460Sihuan Pharmaceutical Holdings Group | HK$1.28 | 0% | -59.2% | HK$11.9b | HK$3.32 | PE24.5x | E34.8% | 9.9% | ||
| 2157Lepu Biopharma | HK$6.84 | -2.1% | n/a | HK$11.4b | HK$7.20 | PB11.6x | S85.9% | n/a | ||
| 2179Jiangsu Recbio Technology | HK$22.75 | 1.1% | n/a | HK$11.0b | HK$33.77 | PS1514.3x | E77.3% | n/a |